Cholecalciferol for prophylaxis against antituberculosis therapy-induced liver disorders among naïve patients with pulmonary tuberculosis: A randomized, comparative study

Cholecalciferol for prophylaxis against antituberculosis therapy-induced liver disorders among naïve patients with pulmonary tuberculosis: A randomized, comparative study

Background: Patients in countries endemic for chronic viral hepatitis are more vulnerable to antituberculosis therapy-induced liver disorders (ATT-LDs). The aim of this study was to explore the role of cholecalciferol in prophylaxis against ATT-LD among patients with pulmonary tuberculosis (TB) rece...

Full description

Bibliographic Details
Main Authors: Ahmad Farooq Alsayed Hasanain, Ali Abdel-Azeem Hasan Zayed, Reem Ezzat Mahdy, Amany Mohamed Adawi Nafee
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:International Journal of Mycobacteriology
Subjects:
Antituberculosis therapy
cholecalciferol
liver disorders
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=2;spage=149;epage=155;aulast=Hasanain

Internet

http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=2;spage=149;epage=155;aulast=Hasanain

Similar Items